Can Loxo Oncology, Inc. (LOXO)’s Tomorrow be Different? The Stock Just Broke Its High

May 16, 2018 - By Dolores Ford

Loxo Oncology, Inc. (NASDAQ:LOXO) Logo

Investors sentiment decreased to 0.97 in 2017 Q4. Its down 0.76, from 1.73 in 2017Q3. It dived, as 29 investors sold Loxo Oncology, Inc. shares while 43 reduced holdings. 23 funds opened positions while 47 raised stakes. 124.82 million shares or 329.48% more from 29.06 million shares in 2017Q3 were reported.
Cornerstone Cap Management Holdg Limited Company, a New York-based fund reported 4,800 shares. Dekabank Deutsche Girozentrale stated it has 0.01% of its portfolio in Loxo Oncology, Inc. (NASDAQ:LOXO). Principal Fincl Grp Inc Inc invested in 0% or 8,442 shares. Pnc Fincl Ser Gp Incorporated invested in 0% or 14,158 shares. Millennium Management Limited Liability Com invested 0% in Loxo Oncology, Inc. (NASDAQ:LOXO). Gam Ag holds 0.14% of its portfolio in Loxo Oncology, Inc. (NASDAQ:LOXO) for 55,600 shares. Qs Limited Com holds 0% or 1,400 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,083 shares. Credit Suisse Ag reported 0.01% in Loxo Oncology, Inc. (NASDAQ:LOXO). Ser Automobile Association invested in 67,176 shares. Atlantic Tru Limited Liability Corp, Georgia-based fund reported 175 shares. Columbia Wanger Asset Ltd Company invested in 455,685 shares. The United Kingdom-based Ahl Prtnrs Llp has invested 0% in Loxo Oncology, Inc. (NASDAQ:LOXO). National Bank & Trust Of America De reported 12,944 shares. Orbimed Advisors Ltd Liability Co reported 94.10 million shares stake.

Since December 8, 2017, it had 0 insider purchases, and 20 insider sales for $73.97 million activity. 250,000 Loxo Oncology, Inc. (NASDAQ:LOXO) shares with value of $20.63M were sold by Bonita David P. $1.97M worth of Loxo Oncology, Inc. (NASDAQ:LOXO) was sold by Bilenker Joshua H.. On Monday, February 12 the insider Burstein Jennifer sold $158,504. Another trade for 15,000 shares valued at $1.50 million was made by Naider Avi Z. on Monday, January 22. ORBIMED ADVISORS LLC sold $20.63M worth of stock or 250,000 shares. AISLING CAPITAL III LP also sold $20.13 million worth of Loxo Oncology, Inc. (NASDAQ:LOXO) shares.

The stock of Loxo Oncology, Inc. (NASDAQ:LOXO) hit a new 52-week high and has $152.93 target or 8.00 % above today’s $141.60 share price. The 7 months bullish chart indicates low risk for the $4.26B company. The 1-year high was reported on May, 16 by Barchart.com. If the $152.93 price target is reached, the company will be worth $340.72 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 0.73% or $1.02 during the last trading session, reaching $141.6. About 303,144 shares traded. Loxo Oncology, Inc. (NASDAQ:LOXO) has risen 146.80% since May 16, 2017 and is uptrending. It has outperformed by 135.25% the S&P500.

Loxo Oncology, Inc. (NASDAQ:LOXO) Ratings Coverage

Among 6 analysts covering Loxo Oncology (NASDAQ:LOXO), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Loxo Oncology has $151 highest and $102.0 lowest target. $126.60’s average target is -10.59% below currents $141.6 stock price. Loxo Oncology had 9 analyst reports since November 28, 2017 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, March 1. The rating was maintained by Citigroup with “Buy” on Monday, March 5. The firm has “Overweight” rating by Morgan Stanley given on Monday, April 16. The firm has “Buy” rating by Oppenheimer given on Thursday, February 22. BTIG Research maintained it with “Buy” rating and $102.0 target in Wednesday, December 20 report. As per Wednesday, March 21, the company rating was downgraded by Morgan Stanley. Stifel Nicolaus maintained Loxo Oncology, Inc. (NASDAQ:LOXO) on Wednesday, May 9 with “Buy” rating.

More notable recent Loxo Oncology, Inc. (NASDAQ:LOXO) news were published by: Globenewswire.com which released: “Loxo Oncology to Announce First Quarter 2018 Financial Results” on May 01, 2018, also Globenewswire.com with their article: “Loxo Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)” published on May 07, 2018, Benzinga.com published: “5 Biggest Price Target Changes For Wednesday” on May 09, 2018. More interesting news about Loxo Oncology, Inc. (NASDAQ:LOXO) were released by: Nasdaq.com and their article: “Loxo Oncology Reports First Quarter 2018 Financial Results” published on May 08, 2018 as well as Seekingalpha.com‘s news article titled: “The Ongoing Loxo Thesis, Part 2: The Journey Doesn’t End With Larotrectinib” with publication date: May 16, 2018.

Loxo Oncology, Inc., a biopharmaceutical company, develops and sells medicines for patients with genetically defined cancers in the United States. The company has market cap of $4.26 billion. The Company’s lead product candidate comprises larotrectinib, an oral selective inhibitor of tropomyosin receptor kinase , which is in adult Phase 1 trial, a pediatric Phase 1/2 trial, and an adult/adolescent Phase 2 trial for the treatment of patients with tumor types, such as lung, head and neck, melanoma, colorectal, sarcoma, and breast cancer. It currently has negative earnings. The companyÂ’s preclinical programs include LOXO-195, a drug candidate in preclinical development to address predicted acquired resistance mechanisms; RET inhibitor that optimizes potency for rearranged during transfection (RET) fusion proteins, mutations, and anticipated mechanisms of acquired resistance; and FGFR inhibitor that enables potently inhibiting FGFR isoforms comprising four isoforms with tyrosine kinase domains.

Loxo Oncology, Inc. (NASDAQ:LOXO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Science

Chinese satellite Queqiao launched to the moon

Chinese satellite Queqiao launched to the moon

Kelly Oliver

China has recently successfully launched its lunar satellite Queqiao. According to the official plans, the satellite will help with communication between lunar lander and Earth, as well as performing radio astronomy. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest ...

Rocket Antares brings new supplies on International Space Station

Rocket Antares brings new supplies on International Space Station

Edwin Martin

It looks like this launch of Antares rocket was expected more than the flight of first human mission on Mars. And the reason is in cargo itself. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings ...

Sally Ride on a postage stamp

Sally Ride on a postage stamp

Ellis Scott

An astronaut has signed her own photo 35 years ago. She did not know that someday it would be turned into postage stamp of the USA. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with ...

Physics and science fiction met together at Fermilab

Physics and science fiction met together at Fermilab

Dolores Ford

According to the physicist from Fermilab, Cindy Joe stories are an important part of daily work of a scientist. That’s when Story Collider decided to gather storytellers from different sides of science into live shows and podcasts. Receive News & Ratings Via Email - Enter your email address below to receive a ...

Do we need to change our space goals on Venus

Do we need to change our space goals on Venus

Darrin Black

NASA and Donald Trump, the USA president, have big plans on Mars’ exploration and upcoming mission on the red planet. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Why Mars changes its colors

Why Mars changes its colors

Vivian Park

If you are interested in astronomy, you may have noticed that Mars is definitely brighter this year, than it was before 2003 for example. Is it true? Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings ...

Big Bang model will be created on ISS

Big Bang model will be created on ISS

Thomas Roop

Antares rocket with all 7, 400 pounds of supplies on board was successfully launched from Virginia yesterday. It contained Cold Atom Laboratory which is able to freeze atoms to absolute zero temperatures, colder than space vacuum and create Bose-Einstein condensates. Receive News & Ratings Via Email - Enter your email address below ...

Richland meets space plants

Richland meets space plants

Paul Bridgeforth

There is a whole strategy behind ISS agricultural program. At first bags of seeds with dozens of other supplies will fly to the outer space. It will happen on Monday. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news ...

Is it true that girls find physics boring?

Is it true that girls find physics boring?

Paul Bridgeforth

As one parent says if we want to make physics more attractive for girls we need to teach it in a meaningful way, without any gender-specific programs. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings ...

Physics in motion for 10 000 children

Physics in motion for 10 000 children

Orlando Souther

Children could see the real attraction of physics during the Physics Day at Lagoon. It is the 29th year of physics celebration. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email ...